Cerulean appoints interim CFO
This article was originally published in Scrip
Executive Summary
Cerulean Pharma, a company developing new drugs for use against various cancers, has appointed Gregg Beloff interim chief financial officer. Mr Beloff joins Cerulean as a member of Danforth Advisors, a consulting firm specializing in providing financial and strategic support to life sciences companies. Previously, Mr Beloff was CFO of two public and three privately held companies, in addition to his consulting clients.